Monitor Nasdaq hearing panel outcome for potential delisting, which would severely impact liquidity and equity value. Track remediation of material weaknesses and statutory filing deadlines with state insurance regulators. The CFO vacancy and regulatory examination add execution risk.
Price Chart
Executive Summary
Atlantic American Corporation filed Amendment No. 1 to its 2025 Form 10-K solely to insert a previously omitted auditor signature and file a revised consent of independent registered public accounting firm. The amendment does not modify the original filing's financial statements or disclosures. However, the original 10-K disclosed three material weaknesses in internal control over financial reporting, a non-cash error correction reducing 2024 retained earnings by $1.485 million, and ongoing Nasdaq noncompliance due to delinquent filings, with a delisting determination expected.
Key Facts
- Amendment No. 1 to 2025 Form 10-K filed solely to insert omitted auditor signature and file revised consent — no changes to financial statements.
- Original 10-K disclosed three material weaknesses: (1) group premium receivables/suspense cash application, (2) LDTI implementation and long-duration contract valuation, (3) income tax accounting.
- Non-cash error correction reduced 2024 insurance premiums and other receivables by $5.580 million, retained earnings by $1.485 million, and increased 2024 net loss by $0.277 million.
- Nasdaq noncompliance: Company expects staff delisting determination after failing to file delinquent reports by October 12, 2026 extension deadline; intends to appeal.
- CFO J. Ross Franklin resigned effective May 27, 2026; successor not yet named.
- Bankers Fidelity has not filed annual audited statutory financial statements for FY2025 or quarterly statutory statements for Q2 2026 with state regulators.
- Nebraska Department of Insurance commenced a regulatory examination of an applicable insurance subsidiary on August 24, 2026.
- Net income swung to $6.0 million in 2025 from a net loss of $1.4 million in 2024, driven by premium growth and $4.5 million unrealized gains on equity securities.
- Total revenue increased to $210.4 million in 2025 from $188.1 million in 2024; operating income was $3.7 million vs. an operating loss of $1.3 million.
- Junior subordinated debentures of $33.7 million outstanding; revolving credit facility borrowings of $5.0 million at December 31, 2025.
Financial Impact
Error correction reduced 2024 retained earnings by $1.485 million and increased 2024 net loss by $0.277 million. No cash impact. Three material weaknesses in internal control over financial reporting identified.
Risk Factors
- Nasdaq delisting could lead to suspension of trading suspension or permanent delisting, reducing liquidity and access to capital markets.
- Failure to file remaining delinquent reports (Q1 and Q2 2026 10-Qs could trigger further credit agreement defaults beyond those already waived.
- Regulatory action by state insurance departments if Bankers Fidelity fails to file statutory financial statements by applicable deadlines.
- Material weaknesses in internal control over financial reporting may lead to future restatements or additional control deficiencies.
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001140361-26-039951 |
| Document: ef20083985_ex31-2.htm | 0001140361-26-039951 |
| Document: ef20083985_ex31-1.htm | 0001140361-26-039951 |
| Document: ef20083985_ex32-1.htm | 0001140361-26-039951 |
| Document: ef20083985_ex21-1.htm | 0001140361-26-039951 |
| Document: ef20083985_ex23-1.htm | 0001140361-26-039951 |
| Document: 0001140361-26-039951-index-headers.html | 0001140361-26-039951 |
| Document: 0001140361-26-039951-index.html | 0001140361-26-039951 |
| Document: 0001140361-26-039951.txt | 0001140361-26-039951 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | DEF 14A | $1.24 | awaiting T+20 | — | $1.28 (+3.63%) |
Oct 22, 2026 4d ago | 8-K | $1.24 | awaiting T+20 | — | $1.28 (−3.63%) |
Oct 22, 2026 4d ago | Press Release | $1.24 | awaiting T+20 | — | $1.28 (−3.63%) |
Oct 16, 2026 10d ago | 10-K/A | $1.45 | awaiting T+20 | — | $1.28 (+11.38%) |
Oct 16, 2026 10d ago | 8-K | $1.05 | awaiting T+20 | — | $1.28 (−22.38%) |
Aug 26, 2026 8w ago | 8-K | $1.57 $1.31 | ▲ +16.56% | ▲ +16.05% | $1.28 (+18.15%) |
Aug 26, 2026 8w ago | Press Release | $1.57 $1.31 | ▲ +16.56% | ▲ +16.05% | $1.28 (+18.15%) |
May 22, 2026 22w ago | 8-K | $2.16 $1.79 | ▲ +17.13% | ▲ +15.18% | $1.28 (+40.51%) |
May 22, 2026 22w ago | Press Release | $2.16 $1.79 | ▲ +17.13% | ▲ +15.18% | $1.28 (+40.51%) |
May 5, 2026 24w ago | 8-K | $2.51 $1.92 | ▼ −23.51% | ▼ −26.29% | $1.28 (−48.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers